Indian Pharmaceutical Sector Sees Strong Export Momentum in FY26
Global demand for generic medicines boosts growth prospects for Indian drug manufacturers.
Hyderabad: India’s pharmaceutical industry recorded strong export momentum during FY26 as demand for affordable generic medicines increased across global markets.
Industry leaders said Indian drug manufacturers continue benefiting from competitive production costs, regulatory approvals and expanding international healthcare demand.
Exports to North America, Africa and Southeast Asia witnessed healthy growth during the first months of the fiscal year.
Pharmaceutical companies are also investing heavily in research, biologics and specialty medicine production to diversify revenue streams.
Experts noted that supply-chain resilience and quality compliance remain crucial for sustaining India’s reputation as a leading global pharmaceutical supplier.
Healthcare economists believe India’s pharma sector will continue playing a vital role in the global healthcare ecosystem.
